Research Insight
Pharma 2020
A recent study by PricewaterhouseCoopers (PwC) examined the future of pharma and revealed essential technological and IT strategies. Developments in manufacturing, research and development...
Research Insight
Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes, India
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics. The drug was discovered...
Techno Trends
Avisoft Bioacoustics – Monitoring Equipment for Mice and Rat Ultrasonic Vocalisations
Avisoft Bioacoustics provides cutting-edge equipment for monitoring mice and rat ultrasonic vocalisations (USV) in drug development procedures and basic research in neuroscience. USV are...
News
European Commission grants marketing approval for Teva’s DuoResp Spiromax
Teva Pharmaceutical has obtained marketing authorisation approval from European Commission for its DuoResp Spiromax for treatment of patients with asthma and chronic obstructive pulmonary...
News
GSK and MMV initiate Phase III programme for development of malaria drug
GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) have initiated a Phase III global programme to assess the efficacy and safety of tafenoquine, an...
News
Ohr Pharma completes patient enrolment in Phase II trial of macular degeneration drug
US-based Ohr Pharmaceutical has completed patient enrolment in its OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for treatment of the wet form...
News
Bavarian Nordic doses first patient in Phase II trial of CV-301 to treat bladder cancer
Denmark-based biotechnology firm Bavarian Nordic has dosed first patient in a randomised, prospective Phase II trial of its active immunotherapy product candidate CV-301 for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read